1. Home
  2. LGHLW vs INM Comparison

LGHLW vs INM Comparison

Compare LGHLW & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGHLW
  • INM
  • Stock Information
  • Founded
  • LGHLW N/A
  • INM 1981
  • Country
  • LGHLW China
  • INM Canada
  • Employees
  • LGHLW N/A
  • INM N/A
  • Industry
  • LGHLW Investment Bankers/Brokers/Service
  • INM Biotechnology: Pharmaceutical Preparations
  • Sector
  • LGHLW Finance
  • INM Health Care
  • Exchange
  • LGHLW Nasdaq
  • INM Nasdaq
  • Market Cap
  • LGHLW N/A
  • INM 3.2M
  • IPO Year
  • LGHLW N/A
  • INM N/A
  • Fundamental
  • Price
  • LGHLW $0.01
  • INM $2.98
  • Analyst Decision
  • LGHLW
  • INM
  • Analyst Count
  • LGHLW 0
  • INM 0
  • Target Price
  • LGHLW N/A
  • INM N/A
  • AVG Volume (30 Days)
  • LGHLW N/A
  • INM 54.4K
  • Earning Date
  • LGHLW N/A
  • INM 05-13-2025
  • Dividend Yield
  • LGHLW N/A
  • INM N/A
  • EPS Growth
  • LGHLW N/A
  • INM N/A
  • EPS
  • LGHLW N/A
  • INM N/A
  • Revenue
  • LGHLW N/A
  • INM $4,832,013.00
  • Revenue This Year
  • LGHLW N/A
  • INM N/A
  • Revenue Next Year
  • LGHLW N/A
  • INM N/A
  • P/E Ratio
  • LGHLW N/A
  • INM N/A
  • Revenue Growth
  • LGHLW N/A
  • INM N/A
  • 52 Week Low
  • LGHLW N/A
  • INM $1.72
  • 52 Week High
  • LGHLW N/A
  • INM $15.70
  • Technical
  • Relative Strength Index (RSI)
  • LGHLW N/A
  • INM 58.03
  • Support Level
  • LGHLW N/A
  • INM $2.85
  • Resistance Level
  • LGHLW N/A
  • INM $3.10
  • Average True Range (ATR)
  • LGHLW 0.00
  • INM 0.25
  • MACD
  • LGHLW 0.00
  • INM 0.06
  • Stochastic Oscillator
  • LGHLW 0.00
  • INM 78.44

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Share on Social Networks: